medic suppli devic
chart week firepow
messag med-tech activ slow sector pace
announc fewest transact sinc total deal valu set come
second straight year vs acquir remain
focus smaller tuck-in asset case slowdown attribut
compani still digest prior deal work intern issu
think gener healthi fundament across large-cap group
still elev valuat publicli trade small-cap med-tech compani like
dampen activ well see assess potenti sector
pick week cotw analyz balanc sheet capac across
mid-to-larg cap group
med-tech activ slow theme last year
remain intact deal announc year date pace
slowest year sinc term overal activ continu theme
averag deal size low sector commit
second straight year spend respect
deal announc skew sharpli toward privat asset
privat compani target transact second year row
account believ shift driven least
part valuat across publicly-trad small-cap med-tech group still
well histor averag today despit moder somewhat
high fundament across large-cap med-tech also quit strong perhap lead
reduc sens urgenc manag team explor inorgan growth opportun
plu side balanc sheet across sector remain rel healthi today
averag large-cap compani carri gross debt ltm ebitda ratio
three compani sit net basi get sens
much firepow remain potenti deal across industri analyz
balanc sheet mid-to-larg cap med-tech compani
methodolog calcul current net debt trail ebitda ratio compani
made adjust transact alreadi announc
yet close legal liabil like result cash outflow next
year final estim larg deal compani could potenti pursu
without take pro forma leverag ratio high end assum
multipl acquir ebitda premium current lc med-tech averag
low end estim assum acquir ebitda consist earlier
analysi suggest group avail balanc sheet
capac today roughli unchang time last year note without
includ despit primarili pharma stori also hous second largest
medic devic compani world one remain aaa-rat balanc
sheet among corpor absolut balanc sheet capac among
pure play devic compani yet despit state desir manag
activ area compani quiet front believ
could chang geoff martha set take omar ishrak ceo april
rank second list capac also announc ceo
transit robert ford take mile white end mr white
celebr career deal maker abbott larg sidelin sinc
digest st jude aler acquisit elsewher estim
current boast balanc sheet capac percentag
market cap
page analyst certif import disclosur
end spectrum rel limit
balanc sheet flexibl today becton case result compani continu
pay debt acquisit bard boston also deal
absorpt mode close btg acquisit august although cfo
brennan state compani could still alloc increment
even manag focus primarili pay debt execut
view deepest new product growth stori sector see takeaway
recent ndr final zimmer prolong turnaround made de-lever slow
process wake biomet merger net debt-to-ebitda still elev
today howev core busi earli inning believ
multi-year reacceler see ceo bryan hanson express desir
shift zimmer end market exposur toward higher growth adjac expect
compani activ pursu tuck-in opportun
page analyst certif import disclosur
compani includ analysi alc ew
page analyst certif import disclosur
issu research report guggenheim secur llc guggenheim secur research analyst whose name appear report
herebi certifi view express report accur reflect research analyst person view subject
secur issuer discuss herein ii part research analyst compens directli indirectli relat specif
recommend view express research analyst
research analyst research associ receiv compens base upon variou factor includ qualiti research investor client
feedback guggenheim secur llc overal revenu includ invest bank revenu
pleas refer websit company-specif disclosur referenc report http //guggenheimsecur bluematrix com/sellside/
disclosur action disclosur inform also avail complianc madison avenu new york ny
buy describ stock expect provid total return price appreci plu yield within period
neutral describ stock expect provid total return price appreci plu yield plu minu within
sell describ stock expect provid total neg return price appreci plu yield within period
nr invest rate price target temporarili suspend suspens complianc applic regul and/or
cs coverag suspend guggenheim secur llc suspend coverag compani
nc cover guggenheim secur llc cover compani
monitor describ stock whose compani fundament financi monitor financi project opinion
invest merit compani provid
review ur follow releas signific news compani rate temporarili place review suffici
inform obtain assess analyst
guggenheim secur llc methodolog assign rate may includ follow market capit matur growth/valu volatil
expect total return next month price target base sever methodolog may includ restrict analys
market risk growth rate revenu stream discount cash flow dcf ebitda ep cash flow cf free cash flow ev/ebitda price-to-earnings pe/growth
price-to-cf p/fcf premium discount /averag group ev/ebitda premium discount /averag group price-to-earnings sum part net asset valu dividend return
return equiti roe next month
price target assign buy- sell-rat stock price target neutral-r stock provid discret analyst
equiti valuat risk valuat methodolog risk associ cover compani price target cover compani pleas
see recent company-specif research report http //guggenheimlibrari bluematrix com/client/librari jsp contact primari analyst
guggenheim secur llc repres email
research client prospect client disclosur relat guggenheim secur affili research
base current public inform consid reliabl repres accur complet reli
seek updat research appropri variou regul may prevent us certain industri report publish
period basi larg major report publish irregular interv appropri research analyst judgement guggenheim secur
conduct full-servic integr invest bank brokerag busi one affili conduct invest manag
busi guggenheim secur member sipc http //www sipc org salespeopl trader profession may provid oral written
market commentari trade strategi client employe trade account reflect opinion contrari opinion
express research guggenheim secur certain affili conduct invest manag busi trade account
conduct invest busi may make invest decis inconsist recommend view express research
affili offic director employe exclud equiti credit analyst time time long short posit act
princip buy sell secur deriv refer research affili also may sell buy custom
page analyst certif import disclosur
princip basi secur describ herein affili also busi relat compani cover guggenheim
secur research may posit debt compani compani discuss herein
research offer sell solicit offer buy secur constitut person recommend take account
particular invest object financi situat need individu client client consid whether advic recommend
research suitabl particular circumst appropri seek profession advic includ tax advic price valu
invest refer research incom may fluctuat past perform guid futur perform futur return
guarante loss origin capit may occur fluctuat exchang rate could advers effect valu price incom
deriv certain invest
commun constitut offer share public unit kingdom prospectu approv unit
kingdom respect secur consequ commun direct person outsid unit kingdom ii person
profession experi matter relat invest fall within articl servic market act
promot order order iii high net worth entiti fall within articl order iv person may law
commun person togeth refer relev person invest activ commun relat
avail engag relev person person relev person act reli document
content
guggenheim secur llc produc tactic trade idea identifi short-term catalyst-driven trade opportun impact compani within
firm coverag univers tactic trade idea may exist compani report may contrari analyst publish rate
copyright guggenheim secur llc guggenheim finra regist broker-deal right reserv content report
base upon inform obtain sourc guggenheim gener consid reliabl guggenheim make represent warranti
respect accuraci complet timeli suitabl otherwis assum respons updat subsequ event knowledg
guggenheim respons use inform
page analyst certif import disclosur
